Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
The Postbiotic Company has closed a pre-seed round using the FounderCatalyst platform to fund its market entry strategy.
"The Postbiotic Company completed their funding round using the FounderCatalyst platform, all for a fixed fee of £1,495. A very exciting phase of growth lies ahead."
Twelve private investors contributed to the equity round to support customer acquisition and team expansion.
The financing round was led by Soulmates Ventures with backing from several new and existing investors.
"Antiverse is tackling one of the most technically demanding problems in drug discovery. The team’s ability to reduce the development time for de novo therapeutic-grade antibodies in a defined domain to under four months is a significant scientific and operational achievement. This capability, combined with the AI-driven design and in-house labs, positions Antiverse on track to become a global leader and the go-to developer of antibody therapies for the most elusive disease targets in medicine"
ARCH Venture Partners led the oversubscribed round alongside participation from +ND Capital, OMX Ventures, and Meltwind.
"Syndex Bio’s mcPCR platform makes amplifying DNA methylation possible for the first time. This powerful method will redefine the sensitivity and accuracy that is achievable in DNA methylation analysis, opening new possibilities for early detection and disease monitoring."
The funding round was led by SFC Capital to support expansion into NHS England trusts.
"Pontiro was built inside the NHS, alongside the teams who use it every day. That matters. With this investment, we’re taking infrastructure that already works at scale in Wales and making it available to trusts across the country who are navigating the same challenges."
.png)
.png)
